Post Translational Modifications | The N-terminal processed forms LD78-beta(3-70) and LD78-beta(5-70) are produced by proteolytic cleavage after secretion from peripheral blood monocytes. The cleavage to yield LD78-beta(3-70) is probably achieved by DPP4. |
Function | Chemotactic for lymphocytes and monocytes. Is a ligand for CCR1, CCR3 and CCR5. Is an inhibitor of HIV-1-infection. The processed form LD78-beta(3-70) shows a 20-fold to 30-fold higher chemotactic activity and is a very potent inhibitor of HIV-1-infection. LD78-beta(3-70) is also a ligand for CCR1, CCR3 and CCR5. |
Protein Name | C-C Motif Chemokine 3-Like 1G0/G1 Switch Regulatory Protein 19-2Ld78-Beta(1-70Pat 464.2Small-Inducible Cytokine A3-Like 1Tonsillar Lymphocyte Ld78 Beta Protein Cleaved Into - Ld78-Beta(3-70 - Ld78-Beta(5-70 |
Database Links | Reactome: R-HSA-380108Reactome: R-HSA-6783783 |
Cellular Localisation | Secreted |
Alternative Antibody Names | Anti-C-C Motif Chemokine 3-Like 1 antibodyAnti-G0/G1 Switch Regulatory Protein 19-2 antibodyAnti-Ld78-Beta(1-70 antibodyAnti-Pat 464.2 antibodyAnti-Small-Inducible Cytokine A3-Like 1 antibodyAnti-Tonsillar Lymphocyte Ld78 Beta Protein Cleaved Into - Ld78-Beta(3-70 - Ld78-Beta(5-70 antibodyAnti-CCL3L1 antibodyAnti-D17S1718 antibodyAnti-G0S19-2 antibodyAnti-SCYA3L1.CCL3L3 antibody |
Information sourced from Uniprot.org